Learn about our Editorial Policies. In a study published in Nature Communications, scientists reported a novel strategy to deliver the CRISPR-Cas9 gene-editing system into the lungs of a cystic ...
Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...
Living with cystic fibrosis means constantly navigating the emotional and physical strain of waiting. Despite the exhaustion and uncertainty, waiting reminds us of our ability to endure in the face of ...
Sionna Therapeutics recently secured an initial public offering (IPO) of $191m on the Nasdaq stock exchange, signalling ...
“Additionally, about 20% of patients with cystic fibrosis but less than 0.5% of ... is now investigating peanut sensitization in a mouse model with homozygous CFTR mutations,” Leeds told ...
IFLScience on MSN11d
Inhalable Cystic Fibrosis Gene Therapy 24 Years In The Making Enters Clinical TrialsA new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...
Airway inflammation plays a central role in the pathophysiology of various chronic lung diseases, such as cystic fibrosis (CF), asthma ... A predictive model using nine VOCs was sufficiently ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback